Logo

Genetix to Buy Cell-Imaging Company Applied Imaging for $18.3M

Sep 01, 2006
NEW YORK (GenomeWeb News) – Genetix Group today said it plans to acquire Applied Imaging, a maker of automated imaging and image-analysis systems, for $18.3 million in cash.
 
Genetix is based in New Milton, on the southern coast of England. The company designs, develops, and manufactures technologies involved in a wide array of cell screening, genomic, and proteomic applications.
 
Applied Imaging, based in San Jose, Calif., sells instruments for cytogenetic testing, among other applications. Genetix is hoping that the acquisition will expand its cell-imaging and -analysis play and boost its presence in the US.
 
“Genetix's cell biology instruments and reagents complement Applied Imaging's imaging and image analysis systems and will help both companies to expand in the US, Europe, and Asia," added Genetix CEO Mark Reid.
 
Terms of the deal call for Genetix to pay $3.06 per share to acquire all of Applied Imaging's common stock. The transaction is expected to close in the fourth quarter.

Breaking News
The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.